Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Juliusson

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Management of non-Hodgkin lymphoma in adults in Scandinavia, United Kingdom, and The Netherlands. Report from the European School of Oncology intercity meeting at Huddinge Hospital, 3rd June, 1988G Juliusson, A F Abrahamsen, E Cavallin-Ståhl, et al.
Leukemia|April 20, 2011
Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia RegistryS Lehmann, A Ravn, L Carlsson, et al.
Leukemia|August 28, 2012
450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartmentsN Cahill, A-C Bergh, M Kanduri, et al.
The New England Journal of Medicine|September 13, 1990
Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalitiesG Juliusson, D G Oscier, M Fitchett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
P-Glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with P-glycoprotein-positive acute myeloid leukemiaU Tidefelt, J Liliemark, A Gruber, et al.
Bone Marrow Transplantation|May 4, 2010
Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftmentH E Johnsen, C Geisler, E Juvonen, et al.
Blood|September 1, 1995
13q deletions in lymphoid malignanciesY Liu, M Hermanson, D Grandér, et al.
Leukemia|December 6, 2005
Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survivalG Juliusson, R Billström, A Gruber, et al.
Blood Cancer Journal|March 4, 2014
Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experienceV Lazarevic, A-S Hörstedt, B Johansson, et al.
NPJ Precision Oncology|September 6, 2018
A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic LeukemiaA Ljungars, L Mårtensson, J Mattsson, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Management of non-Hodgkin lymphoma in adults in Scandinavia, United Kingdom, and The Netherlands. Report from the European School of Oncology intercity meeting at Huddinge Hospital, 3rd June, 1988G Juliusson, A F Abrahamsen, E Cavallin-Ståhl, et al.
Leukemia|April 20, 2011
Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia RegistryS Lehmann, A Ravn, L Carlsson, et al.
Leukemia|August 28, 2012
450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartmentsN Cahill, A-C Bergh, M Kanduri, et al.
The New England Journal of Medicine|September 13, 1990
Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalitiesG Juliusson, D G Oscier, M Fitchett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
P-Glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with P-glycoprotein-positive acute myeloid leukemiaU Tidefelt, J Liliemark, A Gruber, et al.
Bone Marrow Transplantation|May 4, 2010
Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftmentH E Johnsen, C Geisler, E Juvonen, et al.
Blood|September 1, 1995
13q deletions in lymphoid malignanciesY Liu, M Hermanson, D Grandér, et al.
Leukemia|December 6, 2005
Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survivalG Juliusson, R Billström, A Gruber, et al.
Blood Cancer Journal|March 4, 2014
Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experienceV Lazarevic, A-S Hörstedt, B Johansson, et al.
NPJ Precision Oncology|September 6, 2018
A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic LeukemiaA Ljungars, L Mårtensson, J Mattsson, et al.
Pageof 12